Literature DB >> 28240840

Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.

Jasmohan S Bajaj1, Andrew Fagan1, Masoumeh Sikaroodi2, Melanie B White1, Richard K Sterling1, HoChong Gilles1, Douglas Heuman1, Richard T Stravitz1, Scott C Matherly1, Mohammed S Siddiqui1, Puneet Puri1, Arun J Sanyal1, Velimir Luketic1, Binu John1, Michael Fuchs1, Vishwadeep Ahluwalia1, Patrick M Gillevet2.   

Abstract

Liver transplantation (LT) improves daily function and cognition in patients with cirrhosis, but a subset of patients can remain impaired. Unfavorable microbiota or dysbiosis is observed in patients with cirrhosis, but the effect of LT on microbial composition, especially with poor post-LT cognition, is unclear. The aims were to determine the effect of LT on gut microbiota and to determine whether gut microbiota are associated with cognitive dysfunction after LT. We enrolled outpatient patients with cirrhosis on the LT list and followed them until 6 months after LT. Cognition (Psychometric Hepatic Encephalopathy score [PHES]), health-related quality of life (HRQOL), and stool microbiota (multitagged sequencing for diversity and taxa) tests were performed at both visits. Persistent cognitive impairment was defined as a stable/worsening PHES. Both pre-/post-LT data were compared with age-matched healthy controls. We enrolled 45 patients (56 ± 7 years, Model for End-Stage Liver Disease score 26 ± 8). They received LT 6 ± 3 months after enrollment and were re-evaluated 7 ± 2 months after LT with a stable course. A significantly improved HRQOL, PHES, with increase in microbial diversity, increase in autochthonous, and decrease in potentially pathogenic taxa were seen after LT compared with baseline. However, there was continued dysbiosis and HRQOL/cognitive impairment after LT compared with controls in 29% who did not improve PHES after LT. In these, Proteobacteria relative abundance was significantly higher and Firmicutes were lower after LT, whereas the reverse occurred in the group that improved. Delta PHES was negatively correlated with delta Proteobacteria and positively with delta Firmicutes. In conclusion, LT improves gut microbiota diversity and dysbiosis compared with pre-LT baseline but residual dysbiosis remains compared with controls. There is cognitive and HRQOL enhancement in general after LT, but a higher Proteobacteria relative abundance change is associated with posttransplant cognitive impairment. Liver Transplantation 23 907-914 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2017        PMID: 28240840     DOI: 10.1002/lt.24754

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  36 in total

Review 1.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 2.  Altered Microbiome in Patients With Cirrhosis and Complications.

Authors:  Chathur Acharya; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

3.  Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Andrew Fagan; Melanie B White; James B Wade; Phillip B Hylemon; Douglas M Heuman; Michael Fuchs; Binu V John; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

4.  Alterations in gut microbial function following liver transplant.

Authors:  Jasmohan S Bajaj; Genta Kakiyama; I Jane Cox; Hiroshi Nittono; Hajime Takei; Melanie White; Andrew Fagan; Edith A Gavis; Douglas M Heuman; Ho Chong Gilles; Phillip Hylemon; Simon D Taylor-Robinson; Cristina Legido-Quigley; Min Kim; Jin Xu; Roger Williams; Masoumeh Sikaroodi; William M Pandak; Patrick M Gillevet
Journal:  Liver Transpl       Date:  2018-05-13       Impact factor: 5.799

Review 5.  Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.

Authors:  Jonel Trebicka; Peer Bork; Aleksander Krag; Manimozhiyan Arumugam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-30       Impact factor: 46.802

Review 6.  The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections.

Authors:  Giuseppe Ancona; Laura Alagna; Andrea Lombardi; Emanuele Palomba; Valeria Castelli; Giulia Renisi; Daniele Dondossola; Massimo Iavarone; Antonio Muscatello; Andrea Gori; Alessandra Bandera
Journal:  Infect Immun       Date:  2021-08-30       Impact factor: 3.441

Review 7.  Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery.

Authors:  Michael Kriss; Keith Z Hazleton; Nichole M Nusbacher; Casey G Martin; Catherine A Lozupone
Journal:  Curr Opin Microbiol       Date:  2018-07-20       Impact factor: 7.934

Review 8.  The gut microbiota in transplant patients.

Authors:  Pearlie P Chong; Andrew Y Koh
Journal:  Blood Rev       Date:  2019-08-29       Impact factor: 8.250

Review 9.  Microbiota, cirrhosis, and the emerging oral-gut-liver axis.

Authors:  Chathur Acharya; Sinem Esra Sahingur; Jasmohan S Bajaj
Journal:  JCI Insight       Date:  2017-10-05

Review 10.  Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD.

Authors:  Manisha Gupta; Pawan Krishan; Amarjot Kaur; Sandeep Arora; Nirupma Trehanpati; Thakur Gurjeet Singh; Onkar Bedi
Journal:  Inflamm Res       Date:  2021-07-01       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.